# S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

> **NCT00066794** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 69 (actual)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** sargramostim
- **DRUG:** cyclosporine
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride

## Key facts

- **NCT ID:** NCT00066794
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-02
- **Final completion:** 2010-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2015-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00066794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00066794, "S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00066794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*